Clinical Trial Update: Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of raxibacumab on the immunogenicity of Anthrax Vaccine Adsorbed has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax
• Infections Bacterial

Drugs mentioned

• Raxibacumab (raxibacumab)

Snippet

Sponsor: Emergent BioSolutions | Conditions: Infections, Bacterial | Phase 4 | Status: COMPLETED | Results posted: 2018-01-09